Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBα/NFκB and Enhancing Nrf2/HO-1
Diabetic cardiomyopathy (DCM) is associated with a greater risk of mortality in patients with diabetes mellitus. Currently, no specific treatment has been suggested for DCM treatment. This study demonstrated that myricetin (M) attenuated DCM-associated cardiac injury in mice subjected to streptozoto...
Main Authors: | Hai-han Liao, Jin-xiu Zhu, Hong Feng, Jian Ni, Nan Zhang, Si Chen, Huang-jun Liu, Zheng Yang, Wei Deng, Qi-Zhu Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2017/8370593 |
Similar Items
-
Corrigendum to “Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBα/NFκB and Enhancing Nrf2/HO-1”
by: Hai-han Liao, et al.
Published: (2021-01-01) -
Amelioration of 4-methylguaiacol on LPS-induced inflammation in THP-1 cells through NF-κB/IκBα/AP-1 and Nrf2/HO-1 signaling pathway
by: Dong Rui Zhao, et al.
Published: (2019-04-01) -
Mangiferin Attenuates Myocardial Ischemia-Reperfusion Injury via MAPK/Nrf-2/HO-1/NF-κB In Vitro and In Vivo
by: Kun Liu, et al.
Published: (2019-01-01) -
Beyond NF-κB activation: nuclear functions of IκB kinase α
by: Huang Wei-Chien, et al.
Published: (2013-01-01) -
Role of monoubiquitylation on the control of IκBα degradation and NF-κB activity.
by: Elisa Da Silva-Ferrada, et al.
Published: (2011-01-01)